News
37m
Stars Insider on MSNWhat is chronic obstructive pulmonary disease?According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...
Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.
Frequent consumption of a common drug that acts on the nervous system and treats a range of ailments may lead to faster ...
Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...
Those battling severe asthma, upper respiratory tract diseases, Chronic Obstructive Pulmonary Disease (COPD), Asbestosis and ...
Gabapentin is approved for seizures and post-herpetic neuralgia; gabapentin enacarbil is approved for restless legs syndrome.
“The brain is the gatekeeper of longevity,” said Wyss-Coray. “If you’ve got an old brain, you have an increased likelihood of ...
This acquisition of Verona Pharma reflects the commitment we have to delivering innovative treatments to patients and our ...
A key patent for Merck’s blockbuster drug Keytruda will expire in 2028. The cancer therapy brought the company $29.5 billion last year. Keytruda may also face “ price setting ” from the Inflation ...
After the Veterans Health Administration tweaked its formulary on an asthma and chronic obstructive pulmonary disease therapy, hospitalizations and emergency department visits increased, according to ...
Verona Pharma, a year after receiving regulatory approval for its landmark chronic obstructive pulmonary disease (COPD) treatment, is being acquired by pharmaceutical giant Merck in a deal worth about ...
As summers get drier, both the frequency and the intensity of wildfires have grown, producing more polluting smoke. A fire’s smoke can spread across several states, leaving people at risk for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results